RxAmerica's "New Drug Notification" is a weekly
communication to our customers keeping them abreast of the most
recent FDA drug approvals, new indications on existing drugs,
recently released dosage forms and strengths, newly approved
generics, and market withdrawls. This service enables our customers
to prepare for questions, budget impact, and potential utilization
from new drug entities and indications.
New Brand Drugs:
April 30, 2009 - Savella®
April 13, 2009 - Afinitor®
March 31, 2009 - Ryzolt®
March 19, 2009 - Vimpat®
March 3, 2009 - Degarelix®
March 3, 2009 - Rapaflo®
March 3, 2009 - Aplenzin®
March 2, 2009 - Toviaz®
February 25, 2009 - Uloric®
February 25, 2009 - Acanya®
February 18, 2009 - Latisse®
February 09, 2009 - Kapidex®
January 22, 2009 - Epiduo®
January 02, 2009 - Apriso®
New Generic Drugs:
April 15, 2009 - Generic Adderall XR® Capsules Now Available
April 3, 2009 - Generic Cytomel® Tablets Now Available
April 2, 2009 - Generic Topamax® Tablets Now Available
February 6, 2009 - Generic Depakote ER® Tablets Now Available
February 3, 2009 - Generic Depakote Sprinkle Caps® Now Available
January 5, 2009 - Generic Zerit® Capsules Now Available
Adobe Acrobat Reader is required to view PDF files.
Get
Adobe Reader